πŸ‡ΊπŸ‡Έ FDA
Patent

US 6017880

Inhibition of retrovirus infection

expired A61KA61K38/00A61K45/06

Quick answer

US patent 6017880 (Inhibition of retrovirus infection) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/00, A61K45/06